| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 36 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $409.3K | - | |
| CFO | 26.0K | $177.4K | - | |
| Dir | 7.0K | $47.8K | - | |
| Dir | 7.0K | $47.8K | - | |
| Dir | 7.0K | $47.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2018 | Rosenkranz Roberto Pedro | Director | Sell | 6,000 | $60.00 | $360,000.00 | -17.1% | |
| Jan 23, 2018 | Rosenkranz Roberto Pedro | Director | Sell | 2,000 | $50.00 | $100,000.00 | -2.7% | |
| Jan 22, 2018 | Cotroneo Pat | VP, Finance And CFO | Sale+OE | 25,000 | $48.72 | $1,217,954.34 | -6.2% | |
| Jan 19, 2018 | Neff Thomas B | Chief Executive Officer | Sell | 38,636 | $47.46 | $1,833,514.28 | -0.3% | |
| Jan 18, 2018 | Kurkijarvi Kalevi | Director | Sale+OE | 6,000 | $47.38 | $284,268.00 | -11.9% | |
| Jan 18, 2018 | Rosenkranz Roberto Pedro | Director | Sale+OE | 6,000 | $47.45 | $284,695.00 | -7.4% | |
| Jan 5, 2018 | Neff Thomas B | Chief Executive Officer | Sell | 38,636 | $47.61 | $1,839,553.24 | -0.2% | |
| Dec 29, 2017 | Neff Thomas B | Chief Executive Officer | Sell | 38,636 | $48.39 | $1,869,430.54 | -0.3% | |
| Dec 21, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $44.66 | $1,725,654.45 | -0.3% | |
| Dec 18, 2017 | Kurkijarvi Kalevi | Director | Sell | 2,000 | $42.80 | $85,600.00 | -8.3% |